Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD1 | P21728 | 4/20 | 0.48 |
| ▸ | DRD2 | P14416 | 1/20 | 0.48 |
| ▸ | DRD4 | P21917 | 1/20 | 0.48 |
| ▸ | DRD5 | P21918 | 1/20 | 0.48 |
| ▸ | DRD3 | P35462 | 1/20 | 0.48 |
| ▸ | CYP2A6 | P11509 | 4/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.35 |
| ▸ | ELANE | P08246 | 1/20 | 0.34 |
| ▸ | NAT1 | P18440 | 1/20 | 0.33 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.33 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.32 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.32 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.32 |
| ▸ | HTR7 | P34969 | 1/20 | 0.31 |
| ▸ | HTR2B | P41595 | 1/20 | 0.31 |
| ▸ | TYR | P14679 | 1/20 | 0.31 |
| ▸ | GPR3 | P46089 | 1/20 | 0.31 |
| ▸ | CYP2A13 | Q16696 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10022967 | 0.76 | MKNK1 (0.40) | DRD1DRD2CHRNB2CHRNA4 | |
| SCHEMBL1666926 | 0.73 | DRD1 (0.60) | DRD1DRD2DRD4DRD5DRD3 | |
| SCHEMBL29733602 | 0.71 | DRD1 (0.58) | DRD1DRD2DRD4DRD5DRD3 | |
| SCHEMBL29733609 | 0.71 | DRD1 (0.58) | DRD1DRD2DRD4DRD5DRD3 | |
| SCHEMBL31121357 | 0.70 | PGR (0.41) | HTR7 | |
| SCHEMBL35966 | 0.69 | ALDH1A1 (0.59) | DRD1DRD2DRD4DRD5DRD3 | |
| SCHEMBL30498620 | 0.69 | DRD1 (0.49) | DRD1DRD2DRD4DRD5DRD3 | |
| SCHEMBL20294451 | 0.69 | DRD1 (0.49) | DRD1DRD2DRD4DRD5DRD3 | |
| SCHEMBL29438438 | 0.69 | CA12 (0.52) | DRD1DRD2DRD4DRD5DRD3 | |
| SCHEMBL1313610 | 0.69 | CA12 (0.52) | DRD1DRD2DRD4DRD5DRD3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8932797-B2 | Photoacid generators | DOW GLOBAL TECHNOLOGIES LLC (US) | 2015-01-13 | — | — | US | disclosed |
| US-8907122-B2 | Method of preparing photoacid generating monomer | ROHM AND HAAS ELECTRONIC MATERIAL LLC (US) | 2014-12-09 | — | — | US | disclosed |
| US-8716518-B2 | Photoacid generating monomer and precursor thereof | ROHM AND HAAS ELECTRONIC MATERIALS LLC (US) | 2014-05-06 | — | — | US | disclosed |
| US-20120172555-A1 | PHOTOACID GENERATING MONOMER AND PRECURSOR THEREOF | DOW GLOBAL TECHNOLOGIES LLC | 2012-07-05 | — | — | US | disclosed |
| US-20120172619-A1 | METHOD OF PREPARING PHOTOACID GENERATING MONOMER | ROHM AND HAAS ELECTRONIC MATERIALS LLC | 2012-07-05 | — | — | US | disclosed |
| US-20120141939-A1 | PHOTOACID GENERATORS | U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS NOTES COLLATERAL AGENT | 2012-06-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120141939-A1 | PHOTOACID GENERATORS | F10, GNG2, H1-0 | DRD1 2367/4885DRD2 3064/4885DRD4 3310/4885 |
| US-20120172555-A1 | PHOTOACID GENERATING MONOMER AND PRECURSOR THEREOF | SULT1A1, SULT1E1, SULT2A1 | DRD1 340/4885DRD2 728/4885DRD4 895/4885 |
| US-20120172619-A1 | METHOD OF PREPARING PHOTOACID GENERATING MONOMER | POLL, SULT1A1, SULT1E1 | DRD1 1584/4885DRD2 2713/4885DRD4 2435/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.